Analyst Research

Report Title Price
Thomson Reuters Stock Report - ZHEJIANG MEDICINE CO., LTD. (600216-SH)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Zhejiang Medicine Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Zhejiang Medicine Co., Ltd.
Provider: Wright Reports
$472.00
Buy
Zhejiang Medicine Co., Ltd. (600216) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Zhejiang Medicine Co., Ltd. to Set up Subsidiary


Monday, 21 May 2012 08:00pm EDT 

Zhejiang Medicine Co., Ltd. announced that it will invest RMB 158 million to set up a wholly owned subsidiary in Hangzhou City. The subsidiary will be engaged in the wholesale of medicine and medical equipment. 

Latest Developments for Zhejiang Medicine Co Ltd

Latest Key Developments in Pharmaceuticals

Company Quote

Zhejiang Medicine Co Ltd
(600216.SS)
21.11
0.94 +4.66%
2 Jul 2013